Understanding Competitor Fill Rates, Time-to-Fill, and Physician Experience Strengthens Strategies, Improves Patient Access and Fuels Brand Growth

SOUTH SAN FRANCISCO, Calif.: Claritas Rx, the patient journey experts, announced the availability of AI-powered Performance Benchmarking. The service turns comprehensive specialty data into a real-time view of how brands compare against their competitors. Market Alerts enable brands to respond faster to competitor shifts—such as identifying when patients discontinue a competitor’s therapy—allowing for timely engagement with prescribers. Performance Benchmarking offers the first and only real-world data set that quantifies key market access metrics often invisible in claims, including fill rates, time to fill, discontinuation dates and reasons, and more, across specialty brands.

With in-depth head-to-head comparison of key performance indicators (KPIs)—including fill rates, time-to-fill and physician experience—teams can make smarter, data-driven decisions that strengthen strategies, improve patient access and fuel brand growth.

Claritas Rx Performance Benchmarking allows Market Access executives to:

• Compare brand performance by measuring specific brand KPIs—such as fill rates, abandonment, and time-to-fill—against a custom market basket, therapeutic area, or the entire industry.
• Tailor benchmarking to specific regions, treatment classes, or competitive sets for highly relevant performance evaluation.
• Leverage real-world patient Rx abandonment reason data to measure the effectiveness of payer contracts and optimize your gross-to-net strategy.
• Utilize unique Claritas Rx market basket metadata to benchmark what good looks like for patient services, including hub operations, prior authorization (PA) cycle time, free goods use and more.
• Tokenize and integrate with other data to help identify new commercial opportunities and engage prescribers.
• Augment advanced predictive analytics with rich historical and real-time Rx trends, such as fill rates, patient abandonment/discontinuation dates and reasons, and much more.

“Performance Benchmarking helps clarify your specialty market position by synthesizing your own internal data with insights from analogs and competitors across disease area, treatment method, and market dynamics,” said Michael Fitzgibbons, CEO of Claritas Rx. “Powered by Claritas Rx’s unique pre-dispense patient journey data, this approach sets benchmarks, informs pricing, and enables KPI comparisons for smarter decisions and stronger brand performance.”

Performance Benchmarking Two Ways

There are two ways to implement Claritas Rx Performance Benchmarking: as an ongoing subscription model with a customized interactive dashboard or a bespoke consulting project.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Fonte: Business Wire